216 件 ・ 関連度順
概要と使いどころ
Deconstructs SaaS operating metrics including ARR, NRR, gross retention, magic number, rule of 40, and cohort economics. Use when analyzing SaaS businesses, benchmarking software metrics, or evaluating subscription model health.
日本語の概要は準備中です。原文の説明を表示しています。
Use when the user needs to design, run, or audit product or GTM analytics — metric hierarchies and north stars, funnels, cohort retention, churn, pipeline velocity, forecasting, lead scoring, NRR, A/B tests, or analytical SQL — or uploads a dataset to analyze. Triggers on questions like "why did activation drop", "is this metric meaningful", "review my dashboard", or "what should I measure". For writing the spec that defines a feature's success metrics, use product-spec.
日本語の概要は準備中です。原文の説明を表示しています。
Use when a SaaS founder is deciding on or building a product-led growth motion — assessing PLG readiness, choosing freemium vs free trial vs reverse trial, defining activation and PQLs, designing self-serve onboarding and conversion triggers, building viral loops, or setting up PLG metrics (NRG, activation rate, TTV, NDR, CAC payback) and cohort analysis. Also for hybrid product-led-sales design and PLG-vs-sales-led GTM decisions. Not for paid acquisition channel mix (use channel-expert) or the mechanics of price points and tiers (use pricing).
日本語の概要は準備中です。原文の説明を表示しています。
Analyze queried data for trends, week-over-week comparisons, distributions, funnels, cohorts, top-N lists, anomalies, sanity checks, and report-ready findings. Use after or alongside ClickHouse queries when the user wants insight rather than raw rows.
日本語の概要は準備中です。原文の説明を表示しています。
Analyze queried data for trends, week-over-week comparisons, distributions, funnels, cohorts, top-N lists, anomalies, sanity checks, and report-ready findings. Use after or alongside ClickHouse queries when the user wants insight rather than raw rows.
日本語の概要は準備中です。原文の説明を表示しています。
Use when a task needs the judgment of an Epidemiologist — investigating a disease outbreak and identifying its source, designing a case-control or cohort study to test an exposure hypothesis, calculating attack rates/odds ratios/relative risk from surveillance data, evaluating whether a surveillance system is sensitive and timely enough to catch a real signal, or judging whether an observed case cluster is a true outbreak or expected background variation.
日本語の概要は準備中です。原文の説明を表示しています。
Use when a task needs the judgment of a demographer — building a cohort-component population projection, reconciling fertility/mortality rate estimates against ACS or vital-statistics counts, judging whether a population trend is real or sampling/measurement noise, sizing a census undercount adjustment, or advising a public agency on age-structure-driven facility or service demand.
日本語の概要は準備中です。原文の説明を表示しています。
Use when a task needs the judgment of a Compensation, Benefits, and Job Analysis Specialist — market-pricing a job against salary survey data, scoring a job through a point-factor or IPE job evaluation, running a pay-equity regression or cohort analysis, building or refreshing a salary structure and compa-ratio bands, classifying a job family's FLSA exemption status through the duties test, or modeling benefits plan cost (loss ratio, PEPM, self-funded vs. fully insured). Distinct from hr-people-manager (owns the comp/leveling judgment calls — whether to approve an exception, promote someone into a level), hr-specialist (owns individual-case leave/I-9/ADA/FLSA reclassification for one employee's drifted duties), and compensation-benefits-manager (owns pay philosophy, negotiation-range policy, and the department that runs this work). This role owns the mechanics: the survey match, the point score, the regression, the band math — the analysis those upstream policy and downstream judgment calls are made against.
日本語の概要は準備中です。原文の説明を表示しています。
Analyze behavioral segmentation systems for RFM scoring, cohort tracking, churn propensity, engagement scoring, persona clustering, and journey mapping using behavioral economics frameworks..
日本語の概要は準備中です。原文の説明を表示しています。
Design guidance for program outcome measurement in Salesforce nonprofit orgs: logic model structure, indicator taxonomy, impact reporting design, and grant compliance reporting using NPSP Program Management Module (PMM) or Nonprofit Cloud (NPC) Outcome Management. NOT for configuring PMM programs, cohorts and service deliveries - use admin/npsp-program-management. NOT for setting up grant tracking, funding awards and disbursements - use admin/grant-management-setup.
日本語の概要は準備中です。原文の説明を表示しています。
Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.
日本語の概要は準備中です。原文の説明を表示しています。
Build OncoPrint and co-mutation matrix plots from somatic-variant cohorts using ComplexHeatmap, maftools, and comut.py with alteration-type stacking, sample ordering by mutational burden, mutual-exclusivity overlays, and clinical annotation tracks. Use when visualizing per-sample mutation patterns across recurrent driver genes, comparing alteration classes, or identifying mutually-exclusive / co-occurring driver pairs.
日本語の概要は準備中です。原文の説明を表示しています。
Plot per-gene mutation distributions on a protein-domain map (lollipop / needle plots) showing mutation position, recurrence count, and variant classification with maftools, g3-lollipop, trackViewer, and ProteinPaint. Use when visualizing recurrent mutation hotspots on a single gene's protein, marking domain boundaries from UniProt/Pfam, comparing missense vs truncating distributions, or contrasting two cohorts on the same lollipop.
日本語の概要は準備中です。原文の説明を表示しています。
Build Sankey, alluvial, river, and CONSORT-style flow diagrams to visualize cohort transitions, cell-state changes, or pipeline filtering using ggalluvial, networkD3, plotly, and consort. Use when showing how entities move between categories across timepoints (cell states, drug response classes, patient flow through a trial) or filtering pipelines (variants filtered through QC stages).
日本語の概要は準備中です。原文の説明を表示しています。
Extracts and assigns COSMIC v3.4 mutational signatures (86 SBS / 11 DBS / 18 ID / 21 CN / 16 SV) from somatic VCFs using SigProfilerSuite, MutationalPatterns, MuSiCal mvNMF, SigNet, or HRDetect. Use when characterizing DNA-damage etiology (BRCA1/2 HRD, MMR-D, POLE, APOBEC3A, UV, tobacco, aflatoxin, 5-FU/SBS17b, platinum, colibactin SBS88), routing PARP inhibitor decisions, or auditing de novo extraction vs refit choice for cohort size.
日本語の概要は準備中です。原文の説明を表示しています。
Constructs and validates polygenic risk scores using LDpred2-auto, SBayesRC, MegaPRS, PRS-CS, PROSPER, MUSSEL, BridgePRS, JointPRS, PRSmix, or PGS Catalog Calculator with ancestry-aware reference panels (HapMap3, UKB-LD), ancestry-conditional calibration, and PRS-RS reporting standards. Use when computing PRS for cohorts, applying absolute-risk transformation, assessing cross-ancestry portability (Martin 2017 / Ding 2023 continuous ancestry), or auditing PRS manuscripts against the 22-item PRS-RS reviewer checklist.
日本語の概要は準備中です。原文の説明を表示しています。
Calculate and interpret the PREVENT-ASCVD risk score (10-year and 30-year) for primary prevention of atherosclerotic cardiovascular disease per the 2026 ACC/AHA multisociety dyslipidaemia guideline. Covers inputs required, risk-category thresholds (low <3%, borderline 3–<5%, intermediate 5–<10%, high ≥10%), when to use the 30-year calculation (adults 30–59), and how PREVENT differs from the older Pooled Cohort Equations (lower risk estimates by 40–50%, race-agnostic). Use when a clinician asks what the 10-year ASCVD risk is, how to calculate PREVENT, PCE vs PREVENT, risk category for this patient, does my patient need a statin, 30-year risk calculation, primary prevention risk assessment. Grounded in the 2026 ACC/AHA multisociety dyslipidaemia guideline.
日本語の概要は準備中です。原文の説明を表示しています。
Automate Amplitude tasks via Rube MCP (Composio): events, user activity, cohorts, user identification. Always search tools first for current schemas.
日本語の概要は準備中です。原文の説明を表示しています。
Analytics de produto — PostHog, Mixpanel, eventos, funnels, cohorts, retencao, north star metric, OKRs e dashboards de produto.
日本語の概要は準備中です。原文の説明を表示しています。
医学证据等级排序与编排层 skill。当用户请求"证据等级 / GRADE / 证据排序 / 医学证据评估 / evidence grading / quality of evidence / 系统评价排序 / 临床证据排序 / 证据金字塔"时触发。本 skill 不直接调用 NCBI/Europe PMC/ClinicalTrials API,而是编排 6 个底层原子 skill(pubmed-eutils / europepmc-search / clinical-trials-v2 / aact-bulk-trials / bioc-fulltext-fetch / pubtator-entity-search)的召回结果,按 ChatGPT 推荐的证据金字塔(指南 > Meta > RCT > Cohort > Case-Control > Case Report)做 GRADE 自动评级,自动剔除 editorial / letter / comment。优先使用 BioMCP MCP server 做 fan-out(genomoncology/biomcp),无 BioMCP 时走自建 slow-path 兜底。
日本語の概要は準備中です。原文の説明を表示しています。
医学证据等级排序与编排层 skill - evidence grading orchestrator. 当用户请求"证据等级 / GRADE / 证据排序 / 医学证据评估 / 系统评价排序 / 临床证据排序 / 证据金字塔 / 给 PMID 打分 / Practice Guideline 优先 / Cochrane 优先 / 反向证据交叉验证 / evidence grading / quality of evidence / evidence pyramid / GRADE assessment / Cochrane review ranking / clinical evidence ranking"时,**调用本 skill 进行医学证据自动分级,自动选择最佳信息源**。本 skill 是编排层(L2)·不直接打 NCBI/Europe PMC/ClinicalTrials API,而是编排 6 个底层原子 skill(pubmed-eutils / europepmc-search / clinical-trials-v2 / aact-bulk-trials / bioc-fulltext-fetch / pubtator-entity-search)的召回结果,按证据金字塔(指南 > Meta > RCT > Cohort > Case-Control > Case Report)做 GRADE A/B/C/D 自动评级,自动剔除 editorial/letter/comment。优先使用 BioMCP MCP server 做 fan-out(genomoncology/biomcp);无 BioMCP 时走自建 slow-path 兜底。跨平台无锁(Claude Code / Codex / Gemini CLI)。
日本語の概要は準備中です。原文の説明を表示しています。
Automate Amplitude tasks via Rube MCP (Composio): events, user activity, cohorts, user identification. Always search tools first for current schemas.
日本語の概要は準備中です。原文の説明を表示しています。
Analytics de produto — PostHog, Mixpanel, eventos, funnels, cohorts, retencao, north star metric, OKRs e dashboards de produto.
日本語の概要は準備中です。原文の説明を表示しています。
Query PostHog product analytics via REST API — event analytics, HogQL SQL queries, feature flags, experiments, session recordings, insights, persons, cohorts. Use when the user wants to answer an analytics question, toggle/inspect a flag, or pull event data programmatically without opening the PostHog UI or installing the PostHog MCP.
日本語の概要は準備中です。原文の説明を表示しています。